Acta Scientific Cancer Biology (ASCB) (ISSN: 2582-4473)

Short Communication Volume 5 Issue 11

Tobacco and Cancer: A Terrific Conditional Cross-Talk

Abhimanyu Mohanta*

Biju Pattnaik College, Singda, Mayurbhanj, Odisha, India

*Corresponding Author: Abhimanyu Mohanta, Biju Pattnaik College, Singda, Mayurbhanj, Odisha, India.
DOI: 10.31080/ASCB.2021.04.0352

Received: September 29, 2021; Published: October 15, 2021


The exact history of tobacco use by human is still in dark. But, tobacco and its products have been used in two forms- smoked (combustible) and smokeless (non-combustible) tobacco. Pika (indigenously prepared hand-rolled bidi using a piece of leaf of kendu plant, Diospyros melanoxylon)/, bidi, cigarette, cigars and pipes etc are used as smoked items while khaini, snuff, gutkha, paan masala, betel quids (BQs) etc are used as non-smoked items. According to World Health Organizations, due to tobacco epidemic more than 8 million people are being killed in a year globally. It has also been estimated that more than 7 million of those deaths are due to direct tobacco use while around 1.2 million death cases are the result of non-smokers being exposed to second-hand smoke (SHS) [1]. Epidemiological studies have shown that there is an indomitable nexus between tobacco and cancer. Age, gender and economic status of the tobacco users, type and quantity of tobacco and above all frequency of tobacco use are some of the important conditions involved in the terrific cross-talk between tobacco and cancer.



  1. World Health Organisations (WHO) Global Burden of Disease [database]. Washington, DC: Institute of Health Metrics 2019. IHME (2021).
  2. International Agency for Research on Cancer (IARC). IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Tobacco Smoke and Involuntary Smoking. Lyon, France: IARC Press 83 (2004).
  3. Hoffmann D and Hoffmann I. “The Changing Cigarette: Chemical Studies and Bioassays in Smoking and Tobacco Control Monographs 13”. Bethesda, MD: US: National Cancer Institute (2001): 159-192.
  4. Sasco AJ., et al. “Tobacco smoking and cancer: a brief review of recent epidemiological evidence”. Lung Cancer 45 (2004): S3-S9.
  5. Gavarasana S and Susarla MD. “Palatal mucosal changes among reverse smokers in an Indian village”. Japanese Journal of Cancer Research3 (1989): 209-211.
  6. Erythropel HC., et al. “Formation of flavorant–propylene Glycol Adducts With Novel Toxicological Properties in Chemically Unstable E-Cigarette Liquids”. Nicotine and Tobacco Research9 (2019): 1248-1258.
  7. Tokle R., et al. “Adolescents’ use of nicotine-free and nicotine e-cigarettes: A longitudinal study of vaping transitions and vaper characteristics”. Nicotine and Tobacco Research (2021): ntab192.
  8. Goniewicz ML., et al. “Levels of selected carcinogens and toxicants in vapour from electronic cigarettes”. Tob Control (2013): 1-7.
  9. Wenke G., et al. “A study of betel quid carcinogenesis. II. Formation of Nnitrosamines during betel quid chewing”. In O'Neil IK, von Borstel RC, Miller CT, Long J, and Bartsch H. (eds), N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications no. 57. IARC, Lyon (1984): 859-866.
  10. International Agency for Research on Cancer (IARC). IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, Tobacco Habits other than Smoking; betel-quid and areca-nut chewing; and some related nitrosamines. Lyon, France: IARC 37 (1985).
  11. Li T-L and Shieh Y-S. “The association of betel quid, alcohol cigarettes with salivary glandtumor-Acase-controlstudy”. Journal of Dental Sciences 2 (2017): 151-155.
  12. Mohanta A., et al. “Genotoxicity of tobacco and alcohol on human oral mucosal cells”. European Journal of Experimental Biology 2 (2013): 503-514.
  13. Bhat MY., et al. “Cigarette smoke and chewing tobacco alter expression of different sets of miRNAs in oral keratinocytes”. Scientific Report1 (2018): 7040.


Citation: Abhimanyu Mohanta. “Tobacco and Cancer: A Terrific Conditional Cross-Talk”. Acta Scientific Cancer Biology 5.11 (2021): 26-29.


Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US